Esteban Braggio is an expert in Hematology at Mayo Clinic (United States, Scottsdale) (United States). As of July 2026, ScienceLeadR ranks Esteban Braggio in the top 1% of experts worldwide for Lymphoproliferative Disorders. Esteban Braggio has authored 318 publications, the most recent in 2026. SLR score: 1,042 (community average: 125). How the SLR is computed.

LeadR Profile

Esteban Braggio Mayo Clinic (United States, Scottsdale) United States
1 042 ScienceLeadR Reputation 1042
Network Map

Hematology

Subspecialties: Oncology - Immunology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2004 - 2026

Source: PubMed

Mayo Clinic (United States, Scottsdale)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 318

Citations

Citations: 9 579 1st author: 30 Last author: 26 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.
PMID 42348303 — lymphoma, leukemia, lymphocytic, chronic, b-cell, leukemia, leukemia, lymphoid, sex
Leuk Lymphoma20260
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026.
PMID 42246910 — cells, lymphoma, leukemia, lymphocytic, chronic, b-cell, leukemia, leukemia, lymphoid, protein-tyrosine kinases, tyrosine, therapeutics, receptors, antigen, t-cell
Mayo Clin Proc20260
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myeloma.
PMID 41981199 — cells, genes, plasma cells, multiple myeloma, plasma
NPJ Precis Oncol20260
A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias.
PMID 41904132 — cells, high-throughput nucleotide sequencing, plasma cells, mutation, plasma
Blood Cancer J20260
Genomic Proximity Mapping for Identification of Chromosomal Aberrations in Multiple Myeloma.
PMID 41671398 — hematology, multiple myeloma, chromosome aberrations
Am J Hematol20260

LeadR Networks

Main global connection map